Testimony
IFFGD Founder and President Nancy Norton presented the following testimony on behalf of IFFGD members at a June 27, 2000 Center for Drug Evaluation and Research, Gastrointestinal Drugs Advisory Committee meeting on NDA 21-107, LOTRONEX (alosetron): Thank you, Members of the Committee. I hope you are not going to be tired of hearing from me […]
Gastrointestinal (GI) Motility is defined as the movement of food through the body’s GI tract. The GI tract includes all digestive organs and begins with the mouth and ends with the anus. Another name used by healthcare providers is neurogastromotility. This refers to the relationship between your nervous system and GI tract, and the effect […]
News Article
MOUNT PLEASANT, S.C., Dec. 1, 2025 /PRNewswire/ — This December for Constipation Awareness Month, IFFGD is shedding a light on common causes, prevention, and treatments. As well as promoting healthy conversations and lifestyle habits to support bowel movements. Constipation affects millions, approximately 1 out of every 6-7 people worldwide and annually leading to more than 1.5 million […]
840 Bowel Problems In Adults After Surgical Treatment For Childhood Hirschsprungs
News Article
April is IBS Awareness Month For Immediate Release Media Contact 414-964-1799 Milwaukee, WI (April 5, 2016) – If you think you may have irritable bowel syndrome (IBS), you might be tempted to try treating your symptoms on your own. But, self-treatment can delay effective treatment. Talking to your doctor can put you on the right […]
Disorder
Subtypes of Systemic Mastocytosis There are several types of Systemic Mastocytosis. They differ in how many mast cells build up, where they build up in the various parts of the body, and the types of symptoms that may be experienced. Importantly, all must satisfy the specific diagnostic criteria for Systemic Mastocytosis: How do we treat […]